Fol. Biol. 2016, 62, 67-74

https://doi.org/10.14712/fb2016062020067

Novel CDKL5 Mutations in Czech Patients with Phenotypes of Atypical Rett Syndrome and Early-Onset Epileptic Encephalopathy

Daniela Záhoráková1, M. Langová2, K. Brožová3, J. Laštůvková4, Z. Kalina5, L. Rennerová6, P. Martásek1

1Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic
2Department of Clinical Genetics, Thomayer Hospital in Prague, Czech Republic
3Department of Child Neurology, Thomayer Hospital in Prague, Czech Republic
4Department of Medical Genetics, KZ, a. s. – Masaryk Hospital in Ústí nad Labem, Czech Republic
5Department of Clinical Genetics, University Hospital in Brno, Czech Republic
6Department of Neonatology, KZ, a. s. – Masaryk Hospital in Ústí nad Labem, Czech Republic

Received November 2015
Accepted January 2016

References

1. Allen, R. C., Zoghbi, H. Y., Moseley, A. B., Rosenblatt, H. M., Belmont, J. W. (1992) Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgenreceptor gene correlates with X chromosome inactivation. Am. J. Hum. Genet. 51, 1229-1239.
2. Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., Zoghbi, H. Y. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpGbinding protein 2. Nat. Genet. 23, 185-188. <https://doi.org/10.1038/13810>
3. Bahi-Buisson, N., Kaminska, A., Boddaert, N., Rio, M., Afenjar, A., Gerard, M., Giuliano, F., Motte, J., Heron, D., Morel, M. A., Plouin, P., Richelme, C., des Portes, V., Dulac, O., Philippe, C., Chiron, C., Nabbout, R., Bienvenu, T. (2008a) The three stages of epilepsy in patients with CDKL5 mutations. Epilepsia 49, 1027-1037. <https://doi.org/10.1111/j.1528-1167.2007.01520.x>
4. Bahi-Buisson, N., Nectoux, J., Rosas-Vargas, H., Milh, M., Boddaert, N., Girard, B., Cances, C., Ville, D., Afenjar, A., Rio, M., Heron, D., N’Guyen Morel, M. A., Arzimanoglou, A., Philippe, C., Jonveaux, P., Chelly, J., Bienvenu, T. (2008b) Key clinical features to identify girls with CDKL5 mutations. Brain 131, 2647-2661. <https://doi.org/10.1093/brain/awn197>
5. Bahi-Buisson, N., Bienvenu, T. (2012) CDKL5-related disorders: from clinical description to molecular genetics. Mol. Syndromol. 2, 137-152. <https://doi.org/10.1159/000331333>
6. Bertani, I., Rusconi, L., Bolognese, F., Forlani, G., Conca, B., De Monte, L., Badaracco, G., Landsberger, N., Kilstrup- Nielsen, C. (2006) Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation. J. Biol. Chem. 281, 32048-32056.
7. Carouge, D., Host, L., Aunis, D., Zwiller, J., Anglard, P. (2010) CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiol. Dis. 38, 414-424. <https://doi.org/10.1016/j.nbd.2010.02.014>
8. Chen, Q., Zhu, Y. C., Yu, J., Miao, S., Zheng, J., Xu, L., Zhou, Y., Li, D., Zhang, C., Tao, J., Xiong, Z. Q. (2010) CDKL5, a protein associated with Rett syndrome, regulates neuronal morphogenesis via Rac1 signaling. J. Neurosci. 30, 12777-12786. <https://doi.org/10.1523/JNEUROSCI.1102-10.2010>
9. Diebold, B., Delepine, C., Gataullina, S., Delahaye, A., Nectoux, J., Bienvenu, T. (2014) Mutations in the C-terminus of CDKL5: proceed with caution. Eur. J. Hum. Genet. 22, 270-272. <https://doi.org/10.1038/ejhg.2013.133>
10. Fehr, S., Wilson, M., Downs, J., Williams, S., Murgia, A., Sartori, S., Vecchi, M., Ho, G., Polli, R., Psoni, S., Bao, X., de Klerk, N., Leonard, H., Christodoulou, J. (2012) The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy. Eur. J. Hum. Genet. 21, 266-273. <https://doi.org/10.1038/ejhg.2012.156>
11. Fehr, S., Leonard, H., Ho, G., Williams, S., de Klerk, N., Forbes, D., Christodoulou, J., Downs, J. (2015) There is variability in the attainment of developmental milestones in the CDKL5 disorder. J. Neurodev. Disord. 7, 2. <https://doi.org/10.1186/1866-1955-7-2>
12. Fichou, Y., Nectoux, J., Bahi-Buisson, N., Chelly, J., Bienvenu, T. (2011) An isoform of the severe encephalopathy-related CDKL5 gene, including a novel exon with extremely high sequence conservation, is specifically expressed in brain. J. Hum. Genet. 56, 52-57. <https://doi.org/10.1038/jhg.2010.143>
13. Hagebeuk, E. E., van den Bossche, R. A., de Weerd, A. W. (2013) Respiratory and sleep disorders in female children with atypical Rett syndrome caused by mutations in the CDKL5 gene. Dev. Med. Child Neurol. 55, 480-484. <https://doi.org/10.1111/j.1469-8749.2012.04432.x>
14. Hagebeuk, E. E., Marcelis, C. L., Alders, M., Kaspers, A., de Weerd, A. W. (2015) Two siblings with a CDKL5 mutation: genotype and phenotype evaluation. J. Child Neurol. 30, 1515-1519. <https://doi.org/10.1177/0883073815573317>
15. Kalscheuer, V. M., Tao, J., Donnelly, A., Hollway, G., Schwinger, E., Kubart, S., Menzel, C., Hoeltzenbein, M., Tommerup, N., Eyre, H., Harbord, M., Haan, E., Sutherland, G. R., Ropers, H. H., Gecz, J. (2003) Disruption of the serine/ threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation. Am. J. Hum. Genet. 72, 1401-1411. <https://doi.org/10.1086/375538>
16. Kameshita, I., Sekiguchi, M., Hamasaki, D., Sugiyama, Y., Hatano, N., Suetake, I., Tajima, S., Sueyoshi, N. (2008) Cyclin-dependent kinase-like 5 binds and phosphorylates DNA methyltransferase 1. Biochem. Biophys. Res. Commun. 377, 1162-1167. <https://doi.org/10.1016/j.bbrc.2008.10.113>
17. Kilstrup-Nielsen, C., Rusconi, L., La Montanara, P., Ciceri, D., Bergo, A., Bedogni, F., Landsberger, N. (2012) What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy. Neural. Plast. 2012, 728267. <https://doi.org/10.1155/2012/728267>
18. Lin, C., Franco, B., Rosner, M. R. (2005) CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders. Hum. Mol. Genet. 14, 3775-3786. <https://doi.org/10.1093/hmg/ddi391>
19. Mari, F., Azimonti, S., Bertani, I., Bolognese, F., Colombo, E., Caselli, R., Scala, E., Longo, I., Grosso, S., Pescucci, C., Ariani, F., Hayek, G., Balestri, P., Bergo, A., Badaracco, G., Zappella, M., Broccoli, V., Renieri, A., Kilstrup- Nielsen, C., Landsberger, N. (2005) CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum. Mol. Genet. 14, 1935-1946. <https://doi.org/10.1093/hmg/ddi198>
20. Nectoux, J., Heron, D., Tallot, M., Chelly, J., Bienvenu, T. (2006) Maternal origin of a novel C-terminal truncation mutation in CDKL5 causing a severe atypical form of Rett syndrome. Clin. Genet. 70, 29-33. <https://doi.org/10.1111/j.1399-0004.2006.00629.x>
21. Rademacher, N., Hambrock, M., Fischer, U., Moser, B., Ceulemans, B., Lieb, W., Boor, R., Stefanova, I., Gillessen- Kaesbach, G., Runge, C., Korenke, G. C., Spranger, S., Laccone, F., Tzschach, A., Kalscheuer, V. M. (2011) Identification of a novel CDKL5 exon and pathogenic mutations in patients with severe mental retardation, earlyonset seizures and Rett-like features. Neurogenetics 12, 165-167. <https://doi.org/10.1007/s10048-011-0277-6>
22. Rosas-Vargas, H., Bahi-Buisson, N., Philippe, C., Nectoux, J., Girard, B., N’Guyen Morel, M. A., Gitiaux, C., Lazaro, L., Odent, S., Jonveaux, P., Chelly, J., Bienvenu, T. (2008) Impairment of CDKL5 nuclear localisation as a cause for severe infantile encephalopathy. J. Med. Genet. 45, 172-178. <https://doi.org/10.1136/jmg.2007.053504>
23. Rusconi, L., Salvatoni, L., Giudici, L., Bertani, I., Kilstrup- Nielsen, C., Broccoli, V., Landsberger, N. (2008) CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail. J. Biol. Chem. 283, 30101-30111. <https://doi.org/10.1074/jbc.M804613200>
24. Sharp, A., Robinson, D., Jacobs, P. (2000) Age- and tissuespecific variation of X chromosome inactivation ratios in normal women. Hum. Genet. 107, 343-349. <https://doi.org/10.1007/s004390000382>
25. Schaaf, C. P., Sabo, A., Sakai, Y., Crosby, J., Muzny, D., Hawes, A., Lewis, L., Akbar, H., Varghese, R., Boerwinkle, E., Gibbs, R. A., Zoghbi, H. Y. (2011) Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum. Mol. Genet. 20, 3366-3375. <https://doi.org/10.1093/hmg/ddr243>
26. Stenson, P. D., Mort, M., Ball, E. V., Shaw, K., Phillips, A., Cooper, D. N. (2014) The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum. Genet. 133, 1-9. <https://doi.org/10.1007/s00439-013-1358-4>
27. Tao, J., Van Esch, H., Hagedorn-Greiwe, M., Hoffmann, K., Moser, B., Raynaud, M., Sperner, J., Fryns, J. P., Schwinger, E., Gecz, J., Ropers, H. H., Kalscheuer, V. M. (2004) Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am. J. Hum. Genet. 75, 1149-1154. <https://doi.org/10.1086/426460>
28. Thomas, G. M., Huganir, R. L. (2004) MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci. 5, 173-183. <https://doi.org/10.1038/nrn1346>
29. Weaving, L. S., Christodoulou, J., Williamson, S. L., Friend, K. L., McKenzie, O. L., Archer, H., Evans, J., Clarke, A., Pelka, G. J., Tam, P. P., Watson, C., Lahooti, H., Ellaway, C. J., Bennetts, B., Leonard, H., Gecz, J. (2004) Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am. J. Hum. Genet. 75, 1079-1093. <https://doi.org/10.1086/426462>
30. Williamson, S. L., Giudici, L., Kilstrup-Nielsen, C., Gold, W., Pelka, G. J., Tam, P. P., Grimm, A., Prodi, D., Landsberger, N., Christodoulou, J. (2012) A novel transcript of cyclindependent kinase-like 5 (CDKL5) has an alternative C-terminus and is the predominant transcript in brain. Hum. Genet. 131, 187-200. <https://doi.org/10.1007/s00439-011-1058-x>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive